PL2604689T3 - Środek zapobiegający otyłości oraz zapobiegająca otyłości żywność - Google Patents

Środek zapobiegający otyłości oraz zapobiegająca otyłości żywność

Info

Publication number
PL2604689T3
PL2604689T3 PL12189236T PL12189236T PL2604689T3 PL 2604689 T3 PL2604689 T3 PL 2604689T3 PL 12189236 T PL12189236 T PL 12189236T PL 12189236 T PL12189236 T PL 12189236T PL 2604689 T3 PL2604689 T3 PL 2604689T3
Authority
PL
Poland
Prior art keywords
obesity
food
agent
obesity agent
obesity food
Prior art date
Application number
PL12189236T
Other languages
English (en)
Inventor
Hidetoshi Morita
Toshio Masaoka
Takehito Suzuki
Original Assignee
Nestec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Ltd filed Critical Nestec Ltd
Publication of PL2604689T3 publication Critical patent/PL2604689T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
PL12189236T 2005-07-26 2006-07-25 Środek zapobiegający otyłości oraz zapobiegająca otyłości żywność PL2604689T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005215895 2005-07-26
EP12189236.8A EP2604689B1 (en) 2005-07-26 2006-07-25 Anti-obesity agent and anti-obesity food
EP06781552.2A EP1918373B1 (en) 2005-07-26 2006-07-25 Anti-obesity agent and anti-obesity food

Publications (1)

Publication Number Publication Date
PL2604689T3 true PL2604689T3 (pl) 2015-08-31

Family

ID=37683334

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12189236T PL2604689T3 (pl) 2005-07-26 2006-07-25 Środek zapobiegający otyłości oraz zapobiegająca otyłości żywność

Country Status (9)

Country Link
US (3) US20100216212A1 (pl)
EP (2) EP2604689B1 (pl)
JP (2) JP5144263B2 (pl)
KR (3) KR101411144B1 (pl)
CN (3) CN101370729B (pl)
ES (1) ES2532481T3 (pl)
PL (1) PL2604689T3 (pl)
PT (1) PT2604689E (pl)
WO (1) WO2007013438A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5679576B2 (ja) * 2011-06-06 2015-03-04 東芝エレベータ株式会社 乗客コンベア
KR101394348B1 (ko) * 2011-10-28 2014-05-13 대상에프앤에프 주식회사 대사질환 또는 염증질환 치료 및 예방 효과가 있는 락토바실러스 플란타륨 ｄｓｒ920 및 이의 용도
CN102583145A (zh) * 2012-01-19 2012-07-18 快速电梯有限公司 机械式踏板遗失检测装置及具有该检测装置的自动人行道
SI2854826T1 (sl) * 2012-06-04 2019-03-29 Biogaia Ab Lactobacillus reuteri ATCC PTA6475 za uporabo v preprečevanju ali zdravljenju kostne izgube pri sesalcih
BR112015010639A2 (pt) * 2012-11-12 2017-07-11 Biopolis SL lactobacillus rhamnosus para redução da acumulação de gordura corporal
CA2891618A1 (en) 2012-11-12 2014-05-15 Compagnie Gervais Danone Use of lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance
NZ712617A (en) 2013-04-17 2020-02-28 Suntory Holdings Ltd Bacterium belonging to genus lactobacillus
NZ712603A (en) 2013-04-17 2020-02-28 Suntory Holdings Ltd Composition containing bacterium belonging to genus lactobacillus
WO2015065796A1 (en) 2013-10-31 2015-05-07 E. I. Du Pont De Nemours And Company Aqueous ink-jet inks containing two or more binders
KR102125548B1 (ko) 2015-02-10 2020-06-24 주식회사 지니스 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물
CN109069558A (zh) 2016-03-04 2018-12-21 加利福尼亚大学董事会 微生物聚生体及其用途
WO2018020633A1 (ja) * 2016-07-28 2018-02-01 三菱電機株式会社 乗客コンベアの走行異常検出装置および乗客コンベアの走行異常検出方法
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
JP6400812B1 (ja) * 2017-09-06 2018-10-03 東芝エレベータ株式会社 乗客コンベアの異常検出システム
WO2019168990A1 (en) 2018-02-27 2019-09-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Probiotics and probiotic compositions for regulating body weight
EP3773645A4 (en) 2018-04-10 2021-11-24 Siolta Therapeutics, Inc. MICROBIAL CONSORTIA
EP3599212A1 (en) 2018-07-27 2020-01-29 Otis Elevator Company Drive misalignment monitoring in a people conveyor
US20210196804A1 (en) * 2018-08-22 2021-07-01 Dsm Ip Assets B.V. Sucrose isomerases as food and nutritional supplements
US20210386799A1 (en) * 2018-09-25 2021-12-16 Duke University Methods and compositions to treat and prevent infection
KR102128289B1 (ko) 2019-08-23 2020-06-30 주식회사 엔테로바이옴 아커만시아 뮤시니필라 eb-amdk27 균주 및 그의 용도
CN114786690A (zh) 2019-10-07 2022-07-22 谢尔塔治疗公司 治疗性药物组合物
CN111254090B (zh) * 2019-12-30 2021-11-05 杭州娃哈哈科技有限公司 一株具有减肥功能的罗伊氏乳杆菌及其应用
CN114344344B (zh) * 2022-01-05 2023-06-13 东北农业大学 罗伊氏乳杆菌在缓解高脂饮食诱导小鼠肥胖功能中的应用及含有罗伊氏乳杆菌的复合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
CA2294165C (en) * 1997-07-05 2007-11-27 Societe Des Produits Nestle S.A. Frozen dessert
WO2000064854A1 (fr) * 1999-04-27 2000-11-02 Kabushiki Kaisha Yakult Honsha Esters d'acides gras conjugues
US6641808B1 (en) * 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
JP2001120288A (ja) * 1999-10-29 2001-05-08 Yakult Honsha Co Ltd 共役脂肪酸グリセリド含有脂質の製造法及び組成物
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
JP4157674B2 (ja) * 2000-08-14 2008-10-01 株式会社ヤクルト本社 共役脂肪酸含有発酵食品及びその製造法
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1511502A2 (en) * 2002-06-13 2005-03-09 Alimentary Health Limited Probiotic therapies using lactobacillus reuteri
US20050100531A1 (en) 2002-06-13 2005-05-12 John Bienenstock Probiotic therapies
US6942857B2 (en) 2002-08-09 2005-09-13 Bioneer Corporation Microorganisms for preventing and/or treating obesity or diabetes mellitus
KR100794702B1 (ko) * 2003-07-21 2008-01-14 (주)바이오니아 비만증 또는 당뇨병 예방 및/또는 치료용 미생물
KR100794701B1 (ko) * 2002-08-09 2008-01-14 (주)바이오니아 비만 또는 당뇨 예방 및 치료용 미생물
JP2003081855A (ja) * 2002-08-19 2003-03-19 Yakult Honsha Co Ltd 脂質代謝改善剤およびそれを含有する食品
KR20040027180A (ko) 2002-09-27 2004-04-01 (주)바이오니아 비만 또는 당뇨병의 예방 및 치료 효과를 갖는 유산균발효 유제품 및 그 제조방법
KR20040037011A (ko) * 2002-10-26 2004-05-04 (주)바이오니아 유산균 함유 식품조성물 및 그 제조방법
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
JP2005278414A (ja) * 2004-03-26 2005-10-13 Nippon Shokubai Co Ltd １，３−プロパンジオール及び３−ヒドロキシプロピオン酸を製造する方法
JP2005304362A (ja) * 2004-04-20 2005-11-04 Nippon Shokubai Co Ltd １，３−プロパンジオール及び／又は３−ヒドロキシプロピオン酸を製造する方法
JP2005314038A (ja) * 2004-04-28 2005-11-10 Hitachi Ltd 乗客コンベア
KR100740097B1 (ko) 2005-10-20 2007-07-16 삼성에스디아이 주식회사 배터리의 ｓｏｃ 추정 방법 및 이를 이용한 배터리 관리시스템
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
JP5077157B2 (ja) * 2008-08-04 2012-11-21 高梨乳業株式会社 機能性飲食品
FI123157B (fi) * 2009-05-12 2012-11-30 Valio Oy Probioottien uusi käyttö

Also Published As

Publication number Publication date
KR20140043145A (ko) 2014-04-08
JPWO2007013438A1 (ja) 2009-02-05
EP1918373B1 (en) 2014-08-20
US8637001B2 (en) 2014-01-28
KR20080034474A (ko) 2008-04-21
PT2604689E (pt) 2015-03-09
CN101370729A (zh) 2009-02-18
US20110311501A1 (en) 2011-12-22
JP5144263B2 (ja) 2013-02-13
KR101411144B1 (ko) 2014-06-26
ES2532481T3 (es) 2015-03-27
US20120027736A1 (en) 2012-02-02
CN101233231A (zh) 2008-07-30
WO2007013438A1 (ja) 2007-02-01
US8637000B2 (en) 2014-01-28
CN102225078A (zh) 2011-10-26
CN102225078B (zh) 2012-12-26
EP1918373A4 (en) 2009-02-25
CN101370729B (zh) 2012-08-29
US20100216212A1 (en) 2010-08-26
EP1918373A1 (en) 2008-05-07
JP2011206057A (ja) 2011-10-20
CN101233231B (zh) 2011-06-29
KR20110095929A (ko) 2011-08-25
EP2604689B1 (en) 2015-01-21
EP2604689A1 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
PT2604689E (pt) Agente anti-obesidade e alimento anti-obesidade
IL228770A0 (en) processes and intermediates
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
EP1887067A4 (en) FLUORESCENT AND ITS USE
EP1920216A4 (en) SIGNALING AND LOCATION ORIENTATION
EP1895838A4 (en) COMPOSITIONS AND METHODS
GB0512940D0 (en) Compounds and their use
EP1753468A4 (en) CARBORANYLPORPHYRINS AND USES THEREOF
GB0522660D0 (en) Assembly and device
GB0520743D0 (en) Compounds and their use
ZA200804299B (en) 3-amino-2-arylpropyl azaindoles and uses thereof
IL189252A0 (en) Dihydroxyanthraquinones and their use
EP2061331A4 (en) LACTASE-EATABLE EDIBLE PRODUCTS AND APPROPRIATE PROCEDURES
EP1912921A4 (en) COMPOUNDS ON TETRAAZAPORPHYRINBASE AND ITS USES
EP1778082A4 (en) CARBORANYLPORPHYRINS AND USES THEREOF
EP1943350A4 (en) LATENT PROCYTOTOXINS AND USES THEREOF
EP2058008A4 (en) AGENTS AGAINST FAT SUPPORT AND ITS USE
GB0501348D0 (en) Compositions and methods
GB0520935D0 (en) Integrated processor-template-system and project
GB0518777D0 (en) Products and methods
GB0502843D0 (en) Jig-was and jig-will
GB0522259D0 (en) e-s-spi-l-d-film-cinema-back-engineering armageddon-system and project
GB0517240D0 (en) Chronorotron mk1-system and project
GB0517239D0 (en) Geogrotren-mk1-system and project
GB0515322D0 (en) Ligands and use thereof